NPR explores an issue many others haven’t, reporting that in “three critical months, PhRMA and its member companies spent $40 million lobbying Congress. That’s more than $3 million each week.”
Opinions on other issues in news, journals, PR, advertising, marketing
Monday at #ADA2021, an infectious disease epidemiologist, a journalist, and a researcher shared perspectives on communication of risk in the era of COVID-19: http://ow.ly/ROfR30rMeE7 @AstleyCM @garyschwitzer @berthahidalgo @ADA_DiabetesPro
Shoutouts to @susan_bewley @drkevinknopf @MichaelBaum11 in this call for more than fawning coverage from press releases for these kinds of stories.
Also, linked history inside goes back 5 years just on Grail apparently trying to become Holy Grail. https://twitter.com/garyschwitzer/status/1408849696416841731
Here we go again w/more news about “Blood test finds 50 types of cancer.” And here we see again what’s missing from most such news stories. https://www.healthnewsreview.org/2021/06/blood-test-finds-50-types-of-cancer-weve-been-down-this-path-before/